Skip to content

The effect of pistachio consumption on laboratory parameters in patients with type 2 diabetes

The Effect of crude pistachio consumption on lipid parameters, glucose blood level, inflammatory and Oxidative Stress factors in with type 2 diabetes.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201111155543N3
Enrollment
48
Registered
2012-02-18
Start date
2012-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes. Diabetes mellitus

Interventions

Intervention 1: From experimental group patients will be asked to not change the usual diet, physical activity and lifestyle habits during the study and in their daily snack (morning and Evening) ) a
Lifestyle
From experimental group patients will be asked to not change the usual diet, physical activity and lifestyle habits during the study and in their daily snack (morning and Evening) ) are used from 50
From experimental group patients will be asked to not change the usual diet, physical activity and lifestyle habits during the study.

Sponsors

Qom University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Exclusion criteria: patients with kidney, liver and respiratory therapy, history of allergy to pistachio, smoking and alcohol consumption, female patients undergoing hormone therapy, patients treated with insulin, becoming exposed to severe stress (infections, diabetic foot surgery, severe emotional stress), depression and recreational drug use, risk of kidney stones inclusion criteria: diabetes, according to physician, willingness to participate in the study, awareness to time and place, not being addiction to Narcotics and recreational drugs, the ability to speak and understand Persian.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fasting Blood Sugar. Timepoint: Before the intervention, 8 weeks after the intervention, two weeks after the intervention, 10 weeks after intervention. Method of measurement: blood test (Mg per deciliter).;Triglyceride. Timepoint: Before the intervention, 8 weeks after the intervention, two weeks after the intervention, 10 weeks after intervention. Method of measurement: blood test (Mg per deciliter).;Low-density lipoprotein (LDL). Timepoint: Before the intervention, 8 weeks after the intervention, two weeks after the intervention, 10 weeks after intervention. Method of measurement: blood test (Mg per deciliter).;High-density lipoprotein (HDL). Timepoint: Before the intervention, 8 weeks after the intervention, two weeks after the intervention, 10 weeks after intervention. Method of measurement: blood test (Mg per deciliter).;TOTAL cholesterol. Timepoint: Before the intervention, 8 weeks after the intervention, two weeks after the intervention, 10 weeks after intervention. Method of measurement: blood test (Mg per deciliter).;Total antioxidant. Timepoint: Before the intervention, 8 weeks after the intervention, two weeks after the intervention, 10 weeks after intervention. Method of measurement: blood test (pg/ml).;C-reactive protein (CRP). Timepoint: Before the intervention, 8 weeks after the intervention, two weeks after the intervention, 10 weeks after intervention. Method of measurement: blood test (Mg per deciliter).

Secondary

MeasureTime frame
Blood Pressure. Timepoint: Before the intervention, 8 weeks after the intervention, two weeks after the intervention, 10 weeks after intervention. Method of measurement: Using a barometer (mmHg).;Body mass index (BMI). Timepoint: Before the intervention, 8 weeks after the intervention, two weeks after the intervention, 10 weeks after intervention. Method of measurement: Weight in kilograms divided by height in meters squared.;Fasting blood insulin level. Timepoint: Before the intervention, 8 weeks after the intervention, two weeks after the intervention, 10 weeks after intervention. Method of measurement: pg/ml.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeide Heidari

Qom University of Medical Sciences

heidari_saeide@yahoo.com- sheidari@muq.ac.ir+98 25 1770 4233

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026